Controlled drug release liposome composition

• 收藏
• 分享

专利权人:

TLC Biopharmaceuticals, Inc.;Taiwan Liposome Company; Ltd.;Taiwan Liposome Company, Ltd.

发明人:

Kan, Pei,Tseng, Yun-Long,Ou, Han Chun

申请号：

AU2014233308

公开号：

AU2014233308B2

申请日:

2014.03.15

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/